These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 20651639)
1. A new conjugate meningococcal vaccine (Menveo). Med Lett Drugs Ther; 2010 Jul; 52(1343):59-60. PubMed ID: 20651639 [No Abstract] [Full Text] [Related]
2. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026 [No Abstract] [Full Text] [Related]
3. Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo(®)): profile report. Deeks ED Paediatr Drugs; 2012 Feb; 14(1):63-5. PubMed ID: 22149552 [No Abstract] [Full Text] [Related]
4. Statement on conjugate meningococcal vaccine for serogroups A, C, Y and W135. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) Can Commun Dis Rep; 2007 May; 33(ACS-3):1-23. PubMed ID: 17520774 [No Abstract] [Full Text] [Related]
5. Meningococcal disease control in countries of the African meningitis belt, 2013. Wkly Epidemiol Rec; 2014 May; 89(20):206-14. PubMed ID: 24864346 [No Abstract] [Full Text] [Related]
6. Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):273. PubMed ID: 20224545 [TBL] [Abstract][Full Text] [Related]
8. Contributions of the Norwegian Institute of Public Health to the development of vaccines against serogroup B meningococcal disease. Rosenqvist E; Holst J; Nøkleby H Vaccine; 2007 Jan; 25(6):965-6. PubMed ID: 17052822 [No Abstract] [Full Text] [Related]
9. Toward a meningitis-free world. Black S; Pizza M; Nissum M; Rappuoli R Sci Transl Med; 2012 Feb; 4(123):123ps5. PubMed ID: 22378923 [TBL] [Abstract][Full Text] [Related]
10. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines. Trotter CL; Ramsay ME FEMS Microbiol Rev; 2007 Jan; 31(1):101-7. PubMed ID: 17168998 [TBL] [Abstract][Full Text] [Related]
11. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine. El Bashir H; Heath PT; Papa T; Ruggeberg JU; Johnson N; Sinha R; Balfour G; Booy R Vaccine; 2006 Mar; 24(14):2544-9. PubMed ID: 16417952 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy, safety, and cost-effectiveness of meningococcal vaccines]. Chinese Preventive Medicine Association Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Feb; 40(2):129-135. PubMed ID: 30744260 [TBL] [Abstract][Full Text] [Related]
14. Improved meningitis vaccine for Africa could signal eventual end to deadly scourge. Wkly Epidemiol Rec; 2007 Jun; 82(24):222-4. PubMed ID: 17571448 [No Abstract] [Full Text] [Related]
15. Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project. Soriano-Gabarró M; Rosenstein N; LaForce FM J Health Popul Nutr; 2004 Sep; 22(3):275-85. PubMed ID: 15609780 [TBL] [Abstract][Full Text] [Related]
16. Universal childhood immunisation with pneumococcal vaccine and meningococcal serogroup C vaccine introduced in Germany. Wiese-Posselt M; Hellenbrand W; Siedler A; Mayer C Euro Surveill; 2006 Sep; 11(9):E060907.4. PubMed ID: 17075143 [No Abstract] [Full Text] [Related]
19. Long-term protection in children with meningococcal C conjugate vaccination: lessons learned. Borrow R; Miller E Expert Rev Vaccines; 2006 Dec; 5(6):851-7. PubMed ID: 17184222 [TBL] [Abstract][Full Text] [Related]